Skip to main content
Fig. 1 | Critical Care

Fig. 1

From: A randomized controlled trial to determine whether beta-hydroxy-beta-methylbutyrate and/or eicosapentaenoic acid improves diaphragm and quadriceps strength in critically Ill mechanically ventilated patients

Fig. 1

Consort diagram. We initially screened 345 patients and consent was obtained from 83. Of these, 10 failed to complete initial measurements of diaphragm size and strength, with the remaining 73 patients randomized to the four treatment arms. Several patients were lost or withdrew during the treatment administration phase in each study group (i.e. 3 in the control (placebo), 4 in the EPA, 5 in the HMB and 5 in the HMB + EPA arm) due to death, transfer, or request to be removed from the study. In the remaining patients, we obtained data examining changes in diaphragm strength (PdiTw), diaphragm size, quadriceps strength (QuadTw) and quadriceps size between initial, pre-treatment and final, post-treatment measurements

Back to article page

Critical Care

ISSN: 1364-8535